News

DBT announces the scientific completion of India's first qHPV vaccine ‘CERVAVAC’

Dr. Jitendra Singh, Hon'ble Minister of State of the Ministry of Science and Technology announced India’s first indigenously developed Quadrivalent Human Papillomavirus vaccine 'CERVAVAC'.

Read More

Sep 01, 2022

By : ABLE

ABLE member Bharat Biotech, two others to develop 'variant-proof' Covid-19 vaccine

ExcellGene SA is a Switzerland-based private company offering R&D and manufacturing services for the biopharmaceutical industry. CEPI is a global partnership of public, private, philanthropic and civil society organisations founded to develop vaccine against future epidemics.

Read More

Aug 31, 2022

By : ABLE

ABLE Member Serum Institute scripts a first in the US with Novavax alliance on Covid-19 vaccine

“It is the first vaccine from India to be approved by the USFDA,” Serum Institute of India’s Chief Executive Adar Poonawalla

Read More

Aug 31, 2022

By : ABLE

Seeking solutions for challenges shared by Industries

TechEx.in is scouting solutions for the problem statements shared by our Industry clients as part of the TechNet service offered by us

Read More

Aug 31, 2022

By : Team ABLE

Bharat Biotech completes clinical development for phase III trials and booster doses for BBV154 intranasal covid vaccine.

BBV154 is a recombinant replication-deficient adenovirus vectored vaccine with a pre-fusion stabilized spike protein.

Read More

Aug 30, 2022

By : Team ABLE

 

BioEconomy Conclave 2026

24th February | TAJ MG Road, Bengaluru

Exhibit in the 'India Pavilion' at BIO 2026

June 22-25 | San Diego, USA

Focus Areas

Highlights